Cleviprex (clevidipine butyrate): Recall

| Mar 31, 2010

The recall of 12/2009 has been expanded to include four additional lots. Presence of particulate matter which could potentially reduce blood flow in capillaries, cause mechanical damage to some tissues, or initiate acute or chronic inflammatory reactions.

Related Posts:

  1. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
  2. McNeil Consumer Healthcare Over-The-Counter Products: Recall
  3. GammaGard Liquid, Immune Globulin Intravenous (Human)
  4. Propylthiouracil
  5. EPA Celebrates Children’s Health Month and National Lead Poisoning Prevention Week (AR, LA, NM, OK, TX)

Filed Under: Dangerous Drugs